<DOC>
	<DOCNO>NCT01114997</DOCNO>
	<brief_summary>The purpose prospective , randomize , double-blinded , active-controlled study : To assess effectiveness systemic administration lidocaine esmolol combination ( vs. either drug alone ) result improve postoperative outcome patient undergo abdominal surgery ( e.g. , less pain postoperative constipation , nausea vomiting , fast return bowel function , resumption normal activity daily live ) , lead shorten length hospital stay , maintain hemodynamic stability general anesthesia , administer intravenous adjuvant</brief_summary>
	<brief_title>Effect Lidocaine Esmolol Improve Quality Recovery</brief_title>
	<detailed_description>Finding optimal combination anesthetic adjuvant drug maintain hemodynamic stability surgery challenge ( 1-3 ) . Traditionally , potent opioid analgesic like fentanyl newer analog use purpose . However , use opioid compound associate well-known side effect ( e.g. , ventilatory depression , postoperative nausea vomiting , constipation , ileus , bladder dysfunction , urinary retention , pruritus , drowsiness sedation ) . All common side effect interfere early recovery process contribute delay resumption normal activity ( 4 , 5 ) . Increasingly , non-opioid analgesic ( e.g . β-blockers local anesthetic ) utilized adjuvant drug surgery treatment acute hyperdynamic response ( increase catecholamine release ) surgery , well , facilitation recovery process surgery anesthetic analgesic-sparing effect . The β-blocking drug , esmolol labetalol use alternative short-acting opioid analgesic control transient , acute autonomic response surgery ( 5-8 ) , They show reduce anesthetic requirement intravenous ( propofol ) volatile-based anesthesia ( 6,7,10-13 ) decrease opioid consumption intraoperatively PACU ( 8 ) . They may also improve hemodynamic stability induction emergence anesthesia perioperative early postoperative period facilitate resumption normal activity major surgical procedure . The anesthetic analgesic-sparing effect β -blockers also lead fast emergence anesthesia reduce postoperative opioid side effect ( e.g. , PONV ) ( 14-18 ) . Perioperative intravenous esmolol show improvement perioperative outcome , decrease acute hemodynamic response , reduces anesthetic opioids use anesthesia , facilitate fast emergence anesthesia , reduces intraoperative postoperative opioid requirement , reduces side effect pruritus , constipation , ileus , nausea vomiting ( PONV ) thereby shorten hospital stay . ( 3 , 7 , 13 , 18 ) Local anesthetic like lidocaine posse analgesic , antihyperalgesic anti-inflammatory property . Perioperative intravenous lidocaine show improvement perioperative outcome patient undergo abdominal surgery decrease intraoperative requirement Inhalants/Intravenous agent , opioid consumption , postoperative pain , fatigue , nausea vomiting score , maintain hemodynamic stability , facilitate rapid recovery gastrointestinal function , improve postoperative recovery , fast resumption normal activity daily live shorten length hospital stay , administer adjuvant surgery . ( 19,23-29,33 ) Theoretically , would extremely beneficial administer adjuvant ( patient undergo abdominal surgery ) capable effectively control autonomic response surgery , provide faster recovery few side effect . Preliminary data suggest perioperative effect systemic administration lidocaine esmolol effective facilitating bowel recovery , decrease opioid consumption intra/postoperative period , shorten length hospital stay early recovery . Therefore , design prospective , randomize , double-blinded , active-controlled study test hypothesis systemic administration lidocaine esmolol combination ( vs. either drug alone ) maintenance hemodynamic stability surgery result improve postoperative outcome patient undergo abdominal surgery ( e.g. , less pain postoperative nausea vomiting , fast return bowel function resumption normal activity daily live ) ; lead shorten length hospital stay .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>Patients schedule undergo abdominal surgical procedure Willingness ability sign inform consent document No allergies anesthetic analgesic medication 18 80 year age American Society Anesthesiologists ( ASA ) physical status classification : Class I III adult either sex Women childbearing potential must currently practice acceptable form birth control , negative urine blood pregnancy test Patients systolic blood pressure great 80 less 150 baseline , diastolic blood pressure le 100 baseline . Inability comprehend pain assessment tool . Patients know allergy , hypersensitivity contraindication anesthetic analgesic medication Patients clinicallysignificant medical condition , brain , heart , kidney , endocrine , liver disease , Peptic ulcer disease bleed disorder Patients history hepatic , renal , cardiac failure , organ transplant , diabetes Patients reactive airway disease ( asthma ) Patients seizures Chronic use ßblocker calcium channel blocker Morbid obesity ( body mass index &gt; 40 ) Pregnant lactate woman Subjects history alcohol drug abuse within past 3 month Any condition use medication may interfere conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lidocaine Infusion</keyword>
	<keyword>Esmolol Infusion</keyword>
	<keyword>Anesthetic adjuvant</keyword>
	<keyword>Abdominal surgery</keyword>
	<keyword>Pain management</keyword>
	<keyword>Hemodynamic stability</keyword>
	<keyword>Perioperative outcome</keyword>
</DOC>